Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
Situated in Attleboro, MA, BrightView Health provides a wide range of addiction treatment options for both adults and young adults. This facility offers detox services and diverse programs including intensive outpatient, outpatient, and day treatment to address substance use issues. Employing evidence-supported methods like brief intervention, cognitive behavioral therapy, and community reinforcement plus vouchers, BrightView Health customizes treatment plans to meet the unique needs of each client. The center caters specifically to adult men and women, as well as those who have faced intimate partner violence. With an emphasis on high-quality care and individualized support, this center is committed to guiding individuals toward sustainable recovery.
BrightView Health, located in Arlington, MA, provides a wide range of addiction recovery services for both adults and young individuals. The facility specializes in detox and treatment for substance use, offering intensive outpatient, outpatient, and day treatment options. Employing proven strategies such as cognitive behavioral therapy and community reinforcement with vouchers, BrightView Health customizes treatment plans to meet each person's specific requirements. Specialized programs cater to adult men, women, pregnant or postpartum women, and different age demographics. Committed to delivering high-quality care and individualized support, BrightView Health stands out as a reliable choice for effective rehabilitation services.
BrightView Health located in Massillon, OH, specializes in a wide range of addiction treatment options. The center offers comprehensive services including detox programs and various outpatient treatments. Emphasizing techniques such as cognitive behavioral therapy, anger management, and brief intervention, the approach at BrightView Health is customized to meet the unique needs of each individual. Additionally, specialized programs are available for LGBTQ clients and women who are pregnant or in the postpartum stage. Catering to adults and young adults of diverse backgrounds, this center is committed to providing exceptional care with empathy. For those in search of tailored addiction recovery solutions, BrightView Health is focused on guiding you through the healing process.
BrightView Health, located in Sandusky, OH, delivers targeted addiction recovery services aimed at both adults and young adults. The facility provides detoxification and treatment for substance use through a range of programs, including intensive outpatient, outpatient, and day treatment. Emphasizing personalized care, BrightView Health utilizes several therapeutic methods such as anger management, brief interventions, and cognitive behavioral therapy. The center serves clients of all genders, fostering a holistic and welcoming environment for healing. BrightView Health is distinguished by its dedication to exceptional care and customized treatment plans that assist individuals in their recovery process.
BrightView Health in Erlanger, KY, is dedicated to providing complete addiction recovery care for adults and adolescents. The facility offers detox and substance abuse treatment via intensive outpatient, standard outpatient, and day treatment programs. Employing methods like anger management, brief intervention, and cognitive behavioral therapy, BrightView Health customizes its offerings to meet unique client needs. The center’s personalized strategy serves both male and female individuals. BrightView Health is distinguished by its dedication to superior support and customized recovery plans, presenting a vital option for those in pursuit of successful and encouraging addiction treatment.
BrightView Health, situated in Brighton, MA, delivers an extensive range of services aimed at treating addiction for both adults and young adults. The center specializes in detoxification and substance use recovery through various formats, including intensive outpatient, outpatient, and daytime treatment options. By employing techniques such as brief intervention, cognitive behavioral therapy, and community reinforcement supplemented with vouchers, this facility serves a diverse clientele. It offers specialized programs for adult men, adult women, and those who are pregnant or have recently given birth. BrightView Health is committed to offering exceptional care customized to meet individual requirements, positioning it as an excellent option for individuals seeking effective and tailored addiction rehabilitation.
BrightView Health, located in Cincinnati, OH, provides an array of evidence-supported treatment options for those struggling with substance use issues. Their offerings encompass both standard outpatient programs and intensive outpatient services, along with outpatient detoxification. The center is particularly attentive to the needs of the LGBTQ community and women who are pregnant or in the postpartum phase. Utilizing methods such as cognitive behavioral therapy and anger management techniques, BrightView Health assists both adults and young adults in their fight against addiction. With a commitment to personalized care, this facility guarantees that every client receives effective treatment tailored to their unique circumstances. BrightView Health is focused on guiding clients throughout their recovery process.
Brigham and Women's Faulkner Hospital in Jamaica Plain, Massachusetts, provides hospital inpatient detoxification alongside outpatient detox, partial hospitalization, and medication-assisted treatment with buprenorphine and naltrexone. Adults with substance use and co-occurring disorders are served. Medicare, Medicaid, and TRICARE are accepted.
Bright Futures Treatment Center in Boynton Beach, Florida, offers partial hospitalization, intensive outpatient, and regular outpatient treatment for substance use and co-occurring mental illness, using buprenorphine and naltrexone. Programs serve veterans, older adults, and forensic clients. TRICARE, private insurance, and tribal funds are accepted.
A residential facility in Acton, California, Bright Mission Recovery offers detoxification and short and long-term stays for adults with substance use and co-occurring mental health disorders. Buprenorphine and naltrexone are used, with programs for pregnant women, veterans, and military families. Private insurance and self-pay are accepted, with many languages available.
Located in Northridge, California, Bright Paths Recovery is a residential program providing detoxification and short and long-term stays for adults with substance use and co-occurring mental health disorders. Buprenorphine and naltrexone are used in treatment. Payment options are private health insurance and cash or self-payment.
BrightView Health, located in Stoughton, MA, provides an extensive array of addiction recovery services designed for both adults and young adults. This center specializes in detoxification and offers various levels of substance use treatment, including intensive outpatient, outpatient, and day treatment options. By emphasizing evidence-based methodologies such as cognitive behavioral therapy and community reinforcement with vouchers, BrightView Health delivers personalized care for adult men, adult women, pregnant and postpartum women, and clients of all genders. The center’s dedication to delivering exceptional care and customized programs makes it a prime option for individuals in need of reliable and compassionate rehabilitation support.
Situated in Lawrence, MA, BrightView Health delivers an array of addiction treatment options. The facility specializes in detoxification and various substance use services, offering intensive outpatient programs, outpatient care, and day treatment. With methodologies including brief intervention, cognitive behavioral therapy, and community reinforcement plus vouchers, it serves adult men and women, including those who have faced domestic violence or intimate partner violence. BrightView Health is committed to providing exceptional care and individualized treatment strategies, aimed at assisting adults and young adults of all genders on their path to recovery.
The Brien Center, situated in Pittsfield, MA, delivers targeted support for substance misuse and co-occurring mental health conditions, catering to individuals of all ages. Their core offerings include intensive and standard outpatient services, alongside medication-assisted treatment options like methadone and buprenorphine. Employing proven therapeutic methods such as cognitive behavioral therapy and anger management, the center also features specialized tracks for adult men, adult women, and survivors of domestic abuse, ensuring personalized recovery plans. Open to all genders within the adult and young adult populations, the Brien Center stands as a reliable provider of complete recovery solutions in Pittsfield.
The Brien Center, situated in Pittsfield, MA, is a dedicated facility providing specialized substance use disorder treatment for adult men within a nurturing setting. This center delivers extended residential care, incorporating methodologies such as 12-step facilitation, brief intervention, and motivational interviewing. The program also encompasses options for transitional and sober living, serving a diverse range of adults, seniors, and young adults. Committed to high-quality care, the Brien Center strives to guide individuals toward sustained recovery through tailored treatment strategies and thorough support.
Situated in Bayville, NJ, Bright Harbor Healthcare delivers a wide range of services for addiction recovery. This center focuses on detox and substance use treatment geared towards both adults and young adults. The offerings include intensive outpatient programs, outpatient services, and outpatient detox options. Employing evidence-based methods such as 12-step programs, cognitive behavioral therapy, and motivational interviewing, Bright Harbor Healthcare customizes care for clients dealing with both mental health and substance use issues, as well as those with a history of trauma. The center is open to all genders and fosters a welcoming and supportive atmosphere for those on their path to recovery.
Bright Heart Health, located in Walnut Creek, CA, specializes in outpatient detox services, treatment for substance use disorders, and personalized care for those facing both addiction and mental health issues. Their methodology includes techniques such as anger management, cognitive behavioral therapy, and brief therapeutic interventions. The center offers customized programs for men and women, as well as for individuals with dual diagnoses. Catering to adults and young adults of any gender, Bright Heart Health is dedicated to providing comprehensive care and assistance for those dealing with addiction and mental health difficulties. With options like outpatient methadone, buprenorphine, and naltrexone treatments, this center emphasizes a holistic approach and tailored treatment strategies.
Bright Heart Health Indianapolis, located in Indianapolis, IN, provides outpatient services for detoxification and substance use disorders, along with targeted support for those facing dual mental health issues. This center offers outpatient treatments with methadone/buprenorphine and naltrexone, employing methods like anger management, cognitive behavioral therapy, and brief counseling sessions. Designed for adult men and women, as well as those with combined mental health and substance use disorders, Bright Heart Health Indianapolis effectively serves adults and young adults of all genders in need of comprehensive care for addiction and mental health concerns.
Bright Horizons Behavioral Health, situated in Halethorpe, MD, provides a wide range of treatment options for individuals dealing with substance use issues as well as those facing concurrent mental health challenges in adults or emotional disturbances in children. The center features both intensive outpatient and outpatient programs, offering assistance through treatments like methadone/buprenorphine or naltrexone. Dedicated to approaches such as 12-step support, anger management, and focused interventions, this facility serves active military members, teens, and adult males. Bright Horizons Behavioral Health is committed to delivering personalized care for adults and seniors of all genders, aiming to promote enduring recovery solutions.
Bright Star Healthcare Group, located in McDonough, GA, provides a wide range of outpatient services for individuals facing challenges with substance abuse. The center features dedicated programs designed specifically for adult men, adult women, and those who are pregnant or in the postpartum stage. Catering to both adults and young adults, it implements outpatient treatment options with medications such as methadone, buprenorphine, or naltrexone. Utilizing effective strategies like 12-step facilitation, anger management, and brief intervention, Bright Star Healthcare Group emphasizes personalized treatment and evidence-based methodologies, creating a nurturing and efficient atmosphere for individuals aiming to conquer their addiction.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.